Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 27:55:e11948.
doi: 10.1590/1414-431X2022e11948. eCollection 2022.

In vitro maturation medium supplementation: utilization of repaglinide, L-carnitine, and mesenchymal stem cell-conditioned medium to improve developmental competence of oocytes derived from endometriosis mouse models

Affiliations

In vitro maturation medium supplementation: utilization of repaglinide, L-carnitine, and mesenchymal stem cell-conditioned medium to improve developmental competence of oocytes derived from endometriosis mouse models

E Kalehoei et al. Braz J Med Biol Res. .

Abstract

Endometriosis (EMS) is one of the most prevalent causes for female infertility. Herein, we investigated the effect of the repaglinide (RG), L-carnitine (LC), and bone marrow mesenchymal stem cell-conditioned medium (BMSC-CM) supplementation during in vitro maturation (IVM) on the quality, maturation, and fertilization rates, as well as embryonic quality and development of oocytes derived from normal and EMS mouse model. Immature oocytes were collected from two groups of normal and EMS-induced female NMRI mice at 6-8 weeks of age. Oocytes were cultured in IVM medium unsupplemented (control group), or supplemented with 1 M RG, 0.3 and 0.6 mg/mL LC, and 25 and 50% BMSC-CM. After 24 h of oocyte incubation, IVM rate and antioxidant status were assessed. Subsequently, the rates of fertilization, cleavage, blastulation, and embryonic development were assessed. Our results demonstrated that supplementation of IVM medium with LC and BMSC-CM, especially 50% BMSC-CM, significantly enhanced IVM and fertilization rates, and markedly improved blastocyst development and total blastocyst cell numbers in EMS-induced mice compared to the control group (53.28±0.24 vs 18.09±0.10%). Additionally, LC and BMSC-CM were able to significantly modulate EMS-induced nitro-oxidative stress by boosting total antioxidant capacity (TAC) and mitigating nitric oxide (NO) levels. Collectively, LC and BMSC-CM supplementation improved oocyte quality and IVM rates, pre-implantation developmental competence of oocytes after in vitro fertilization, and enhanced total blastocyst cell numbers probably by attenuating nitro-oxidative stress and accelerating nuclear maturation of oocytes. These outcomes may provide novel approaches to refining the IVM conditions that can advance the efficiency of assisted reproductive technologies in infertile couples.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Histological comparison of normal (A) and endometriosis-induced (B) ovaries of mice (scale bar: 100 μm). A, boxed area shows healthy growing follicle. B, boxed area shows atretic follicles.
Figure 2
Figure 2. Different stages of in vitro maturation of mice oocytes (scale bar: 100 μm). GV: germinal vesicle; GVBD: germinal vesicle breakdown; MII: metaphase II.
Figure 3
Figure 3. Different stages of mouse embryo cleavage at different times of in vitro culture [scale bar: 50 μm (A, B, D), 20 μm (C, E)]. A, 2 cells; B, 4 cells; C, Morula; D, expanded blastocysts; E, hatching blastocysts.
Figure 4
Figure 4. Differential staining of mice blastocyst after 5 days of in vitro culture (scale bar: 20 μm). ICM: inner cell mass, stained with propidium iodide would appear red. TE: trophectoderm, nuclei labeled with Hoechst 33258 would appear blue. Red and blue do not appear because these images are in black and white.

References

    1. Xu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, et al. Oocyte quality is decreased in women with minimal or mild endometriosis. Sci Rep. 2015;5:10779. doi: 10.1038/srep10779. - DOI - PMC - PubMed
    1. Shebl O, Sifferlinger I, Habelsberger A, Oppelt P, Mayer RB, Petek E, et al. Oocyte competence in in vitro fertilization and intracytoplasmic sperm injection patients suffering from endometriosis and its possible association with subsequent treatment outcome: a matched case-control study. Acta Obstet Gynecol Scand. 2017;96:736–744. doi: 10.1111/aogs.12941. - DOI - PubMed
    1. Sanchez AM, Vanni VS, Bartiromo L, Papaleo E, Zilberberg E, Candiani M, et al. Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res. 2017;10:43. doi: 10.1186/s13048-017-0341-4. - DOI - PMC - PubMed
    1. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49. doi: 10.1186/1477-7827-10-49. - DOI - PMC - PubMed
    1. Hamdan M, Dunselman G, Li T, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21:809–825. doi: 10.1093/humupd/dmv035. - DOI - PubMed